The Value of a Panel of Autoantibodies for Predicting the Activity of Lupus Nephritis at Time of Renal Biopsy

Abstract EN

Few studies have correlated serum biomarkers with renal histology, the gold standard for renal activity, in lupus nephritis (LN).

We tested a panel of autoantibodies and complement at the time of kidney biopsy and after treatment.

Anti-dsDNA, anti-nucleosome, anti-ribosome P, and anti-C1q antibodies and C3/C4 were measured in 107 patients with LN at the time of renal biopsy and after 6–12 months and were correlated with clinical/histological parameters.

At multivariate analysis, high titers of anti-C1q antibodies or of anti-dsDNA antibodies ( P = 0.005 , OR = 8.67, CI: 2.03–37.3) were the independent predictors that discriminate proliferative from nonproliferative LN.

All the immunological parameters, except anti-ribosome, showed a significant correlation with activity index but not with chronicity index.

Only anti-C1q showed a significant correlation with the amount of proteinuria ( R = 0.2 , P = 0.03 ).

None of the immunological parameters were predictive of remission at 6 and 12 months.

We found that anti-C1q alone or in combination with anti-dsDNA emerged as the most reliable test in differentiating proliferative and nonproliferative LN.

Anti-C1q was the only test correlated with the clinical presentation of LN.

After treatment, the titre of the autoantibodies was significantly reduced, but none was predictive of remission.